| At least 2 comorbidities | Overweight-Obese | Hypertension | Type II Diabetes Mellitus | Dyslipidaemia | Heart Diseases | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COPD outcome | present | absent | p-value | present | absent | p-value | present | absent | p-value | present | absent | p-value | present | absent | p-value | present | absent | p-value |
At least 2 exacerbations in the last 12 months | 58 (38) | 19 (37) | 0.999 | 61 (36) | 16 (49) | 0.239 | 63 (42) | 14 (25) | 0.037 | 11 (58) | 66 (35) | 0.081 | 13 (29) | 64 (40) | 0.259 | 12 (48) | 65 (36) | 0.332 |
CAT ≥ 10 | 13 (7) | 8 (15) | 0.095 | 19 (10) | 3 (8) | 0.776 | 164 (92) | 58 (88) | 0.436 | 26 (96) | 197 (91) | 0.484 | 57 (93) | 166 (90) | 0.613 | 30 (97) | 193 (90) | 0.326 |
mMRC ≥ 2 | 113 (61) | 34 (61) | 0.999 | 127 (64) | 21 (48) | 0.077 | 113 (61) | 39 (57) | 0.660 | 21 (75) | 132 (59) | 0.151 | 31 (50) | 122 (64) | 0.073 | 24 (75) | 128 (58) | 0.109 |
GOLD 2019-C&D status CAT-based | 60 (40) | 18 (37) | 0.739 | 64 (38) | 14 (45) | 0.548 | 64 (43) | 14 (26) | 0.023 | 13 (62) | 65 (36) | 0.031 | 15 (33) | 63 (40) | 0.395 | 13 (52) | 65 (36) | 0.186 |
GOLD 2019-C&D status mMRC-based | 60 (40) | 19 (37) | 0.869 | 63 (37) | 16 (49) | 0.245 | 65 (43) | 14 (26) | 0.024 | 13 (62) | 66 (36) | 0.031 | 15 (33) | 63 (40) | 0.395 | 13 (50) | 66 (37) | 0.200 |